https://www.selleckchem.com/pr....oducts/rituximab.htm
Compared to antibiotics alone, the combination treatment enhanced the clinical effective rate, shortened the hospital stay, reduced the white blood cell, procalcitonin, and C-reactive protein levels, ameliorated the times to the resolution of fever, cough, and lung rales, and increased the oxygenation index. The evidence indicated that TRQI combined with antibiotics caused no adverse reactions. Our study showed that the combination of TRQI and antibiotics was effective for treating pulmonary infection after ICH. However, high-quality